ES454118A1 - Procedimiento para la obtencion de derivados de flucosamina. - Google Patents

Procedimiento para la obtencion de derivados de flucosamina.

Info

Publication number
ES454118A1
ES454118A1 ES454118A ES454118A ES454118A1 ES 454118 A1 ES454118 A1 ES 454118A1 ES 454118 A ES454118 A ES 454118A ES 454118 A ES454118 A ES 454118A ES 454118 A1 ES454118 A1 ES 454118A1
Authority
ES
Spain
Prior art keywords
glucosamine derivatives
manufacture
increase
glucosamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES454118A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES454118A1 publication Critical patent/ES454118A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procedimiento para la obtención de derivados de glucosamina de fórmula general **(Fórmula)** donde X significa un grupo carbonilo o sulfonilo, R significa un resto alquilo, en caso dado sustituido, o un resto arilo carbocíclico, en caso dado sustituido y, en caso de que X sea el grupo carbonilo, también un resto alcoxi o benciloxi, R1 significa hidrógeno, alquilo, o un resto bencilo en caso dado sustituido, R2 significa hidrógeno o alquilo inferior, R4 y R6 significan hidrógeno, alquilo o un resto bencilo en caso dado sustituido o un resto acilo, R7 significa hidrógeno, alquilo, hidroximetilo, mercaptometilo o fenilo, R8 significa un grupo carboxilo en caso dado esterificado o amidado y R9 significa un grupo carboxilo, en caso dado esterificado o amidado.
ES454118A 1975-12-10 1976-12-10 Procedimiento para la obtencion de derivados de flucosamina. Expired ES454118A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (1)

Publication Number Publication Date
ES454118A1 true ES454118A1 (es) 1978-03-01

Family

ID=4414012

Family Applications (2)

Application Number Title Priority Date Filing Date
ES454118A Expired ES454118A1 (es) 1975-12-10 1976-12-10 Procedimiento para la obtencion de derivados de flucosamina.
ES465514A Expired ES465514A1 (es) 1975-12-10 1977-12-28 Procedimiento para la obtencion de derivados de glucosamina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES465514A Expired ES465514A1 (es) 1975-12-10 1977-12-28 Procedimiento para la obtencion de derivados de glucosamina.

Country Status (30)

Country Link
JP (1) JPS5273820A (es)
AR (2) AR224091A1 (es)
AT (1) AT365607B (es)
AU (1) AU508764B2 (es)
BE (1) BE849214A (es)
CA (1) CA1262400A (es)
CH (2) CH613709A5 (es)
CS (4) CS205027B2 (es)
DD (1) DD129781A5 (es)
DE (1) DE2655500A1 (es)
DK (1) DK154654C (es)
ES (2) ES454118A1 (es)
FI (1) FI64164C (es)
FR (1) FR2361902A1 (es)
GB (1) GB1570625A (es)
GR (1) GR61647B (es)
HK (1) HK32883A (es)
HU (1) HU177970B (es)
IE (1) IE44190B1 (es)
IL (1) IL51076A (es)
MY (1) MY8400123A (es)
NL (1) NL7613666A (es)
NO (1) NO144850C (es)
NZ (1) NZ182837A (es)
PL (4) PL110787B1 (es)
PT (1) PT65946B (es)
SE (1) SE445923B (es)
SG (1) SG11083G (es)
SU (3) SU660589A3 (es)
ZA (1) ZA767333B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH636887A5 (en) * 1976-04-26 1983-06-30 Syntex Inc Process for the preparation of novel immunological adjuvant compounds
EP0002677B1 (en) 1977-12-02 1982-10-13 Takeda Chemical Industries, Ltd. Glucosamine-peptide derivatives and their pharmaceutical compositions
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (de) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung
FI803077A (fi) 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (es) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
WO2006118327A1 (ja) * 2005-04-27 2006-11-09 Oxygenix Co Ltd カチオン性アミノ酸型脂質
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
WO2017103944A1 (en) * 2015-12-15 2017-06-22 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
WO2019040109A1 (en) 2017-08-21 2019-02-28 Celgene Corporation PROCESSES FOR THE PREPARATION OF (S) -TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
NO144850B (no) 1981-08-17
IL51076A0 (en) 1977-02-28
SU747430A3 (ru) 1980-07-23
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
CS205027B2 (en) 1981-04-30
PL110353B1 (en) 1980-07-31
PL110787B1 (en) 1980-07-31
DK154654C (da) 1989-05-08
HK32883A (en) 1983-09-02
BE849214A (fr) 1977-06-09
JPS638118B2 (es) 1988-02-19
PL194291A1 (pl) 1978-10-23
NL7613666A (nl) 1977-06-14
CS205025B2 (en) 1981-04-30
DE2655500A1 (de) 1977-06-23
SE445923B (sv) 1986-07-28
AU2042276A (en) 1978-06-15
AR224091A1 (es) 1981-10-30
HU177970B (en) 1982-02-28
SG11083G (en) 1983-09-16
DK154654B (da) 1988-12-05
IL51076A (en) 1980-09-16
CS205026B2 (en) 1981-04-30
FI64164C (fi) 1983-10-10
DE2655500C2 (es) 1988-12-22
IE44190L (en) 1977-06-10
NZ182837A (en) 1978-07-28
SU1060118A3 (ru) 1983-12-07
DK552476A (da) 1977-06-11
FI64164B (fi) 1983-06-30
DD129781A5 (de) 1978-02-08
PL110794B1 (en) 1980-07-31
IE44190B1 (en) 1981-09-09
FI763541A (es) 1977-06-11
AR220686A1 (es) 1980-11-28
CA1262400A (en) 1989-10-17
CH614718A5 (en) 1979-12-14
MY8400123A (en) 1984-12-31
NO764191L (es) 1977-06-13
CS205028B2 (en) 1981-04-30
PT65946A (en) 1977-01-01
ZA767333B (en) 1977-11-30
PL112672B1 (en) 1980-10-31
AU508764B2 (en) 1980-04-03
NO144850C (no) 1981-11-25
SE7613851L (sv) 1977-06-11
AT365607B (de) 1982-02-10
PT65946B (en) 1978-06-14
ATA909276A (de) 1981-06-15
CH613709A5 (en) 1979-10-15
SU660589A3 (ru) 1979-04-30
ES465514A1 (es) 1978-09-16
JPS5273820A (en) 1977-06-21
FR2361902A1 (fr) 1978-03-17
FR2361902B1 (es) 1980-11-07

Similar Documents

Publication Publication Date Title
ES454118A1 (es) Procedimiento para la obtencion de derivados de flucosamina.
PL304419A1 (en) Urease based vaccine against heliobacter infections
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
EP0362279A4 (en) SAPONINE TOOLS.
ES487046A1 (es) Procedimiento de preparacion de proteoglicanos membranarios bacterianos purificados
EP0024541A3 (en) Vaccine for preventing persistent feline leukemia viremia in cats and process for preparing it
ES442144A1 (es) Un procedimiento para la preparacion de 4'-epi-6'-hidroxida-unomicina.
ES458197A1 (es) Un procedimiento para la preparacion de nuevos peptidoglica-nos.
BE750349A (fr) Vaccin destine a l'immunisation active comprenant comme adjuvant le diethylaminoethyldextrane
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
JPS5275134A (en) Electric charge transfer device
JPS5242592A (en) Process for preparing styene-acrylonitrile copolymers
SE7703770L (sv) Sett att framstella nya aminosockerderivat och anvendning derav som lekemedel
ES476703A1 (es) Procedimiento para preparar una heterovacuna para el trata -miento terapeutico del sindrome de los triconomas.
JPS51121511A (en) Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium
JPS5273826A (en) Preparation of organosilanes
JPS51147869A (en) Turn table equipment driven by linear motor
AU8778582A (en) Polymerized albumin vaccine
ES438834A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzhidriloxi-alquilamina y de sus sales de adicion de aci- dos farmaceuticamente aceptables.
GB1475481A (en) 1-n-alpha-hydroxy-omega-aminoalkanoyl-6-n-methyl-3,4-dideoxy kanamycin b and the production thereof
JPS51125728A (en) Novel non-medical germicides and their preparation
FR2394548A1 (fr) O-derives de thienamycine utiles en tant qu'antibiotiques
JPS542398A (en) Preparation of d-alpha-amino acid
JPS5384100A (en) Preparation of photo-plymerizable silicone compound
JPS5257293A (en) Preparation of novel copolymers

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990503